The available report is connected directly to the listing.
Form / material film360° studio loop
Hyperreal material study08.1 sec / seamless
FORM / LOT RECORD
Linked before ordering.
- 01
- Identity
- 02
- Method
- 03
- Lot match
Weight Management
Available for research
Lot-documented reference material
GLP-2
A synthetic peptide reference material with a traceable lot report for controlled laboratory study.
99.44%
Reported purityCurrent lot DPS-9109868 · UPLC + mass spectrometry
View lot report →
$85
CoA available
One-time research orderNo subscription
Free U.S. shipping · Freeze-dried · CoA available
Lab-reported identityUPLC & mass spectrometry
Lot matchedCoA available
Freeze-driedReference material
Research onlyQualified buyers
01Material details
Review the identity, current reported result, methods, storage note, and document status in the material table below.
02Independent record
Open the independent report above to verify the values published on this page before placing a research order.
03Research-use requirements
For laboratory research only. Never for use in people or animals. Obtain and review the supplier-issued SDS before handling or storage.
04Potential human benefits
- Weight-management potentialDual GIP/GLP-1 signaling can reduce hunger and energy intake. In SURMOUNT-1, the highest-dose tirzepatide group averaged 20.9% weight loss at 72 weeks.
- Blood-sugar regulationTirzepatide improves glucose-dependent insulin release and reduces glucagon when glucose is elevated, a combination that has produced strong A1C reductions in type 2 diabetes trials.
- Cardiometabolic improvementHuman studies have reported smaller waist circumference and improvements in blood pressure, triglycerides, and other metabolic-risk markers alongside weight loss.
The Form standard
Built to be examined,
not assumed.
Every listing keeps the material, current record, and research boundary in one clear review path.
Review the stated analytical methods before ordering.
Presented as a laboratory reference material.
Research only. Never for use in people or animals.
Potential human relevance
Dual-incretin control
with proven metabolic reach.
The identifier used for this listing maps to tirzepatide, a dual GIP/GLP-1 receptor agonist rather than native GLP-2. In large human trials, pharmaceutical tirzepatide produced major reductions in body weight and improved glucose control, making dual-incretin signaling one of the most consequential metabolic approaches in current medicine.
Weight-management potential
Dual GIP/GLP-1 signaling can reduce hunger and energy intake. In SURMOUNT-1, the highest-dose tirzepatide group averaged 20.9% weight loss at 72 weeks.
Blood-sugar regulation
Tirzepatide improves glucose-dependent insulin release and reduces glucagon when glucose is elevated, a combination that has produced strong A1C reductions in type 2 diabetes trials.
Cardiometabolic improvement
Human studies have reported smaller waist circumference and improvements in blood pressure, triglycerides, and other metabolic-risk markers alongside weight loss.
How the potential connects to the biology
Why it may matter
Dual GIP- and GLP-1-receptor signaling associated with the material identified by the listed CAS number.
What studies track
cAMP response, insulin-signaling markers, glucose handling, and metabolic endpoints in defined assay systems.
How strong is the evidence?
Large randomized human trials and approved pharmaceutical indications for tirzepatide. Those outcomes do not establish the performance of this research material.
What remains unknown: This listing is labeled GLP-2, but its listed identifier maps to tirzepatide rather than native GLP-2. Approved-drug outcomes cannot be transferred to a research reference material.
Material details
The essentials.
Key identity and lot details from the current independent CoA.
| Product | GLP-2 |
|---|---|
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | Approximately 4813.5 g/mol |
| Lot result | 99.44% purity; white lyophilized powder |
| Tested by | Horizon Analytical; lot DPS-9109868; UPLC and mass spectrometry |
| Storage | Not stated on the current lot CoA. Obtain and follow the supplier-issued SDS before handling or storage. |
| Lab records | Current lot CoA (PDF) · Request supplier-issued SDS |
SDS status: not currently posted. Request and review the supplier SDS before handling or storage; this page and CoA do not replace it.
Made for research
For in-vitro lab research, method development, and identity testing by qualified research customers.
Proof by lot
The available CoA is tied to this material and lot. Open it above or visit the CoA library.
Clear limits
For laboratory research only. Never for use in people or animals.
Before you order
By ordering, you confirm qualified research-only use.
